P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 121, Issue 5, 2003, Pages 730-738

  Del Principe, Maria Ilaria ^a   Del Poeta, Giovanni ^a   Maurillo, Luca ^a   Buccisano, Francesco ^a   Venditti, Adriano ^a   Tamburini, Anna ^a   Bruno, Antonio ^a   Cox, Maria Christina ^a   Suppo, Giovanna ^a   Tendas, Andrea ^a   Giannì, Laura ^a   Postorino, Massimiliano ^a   Masi, Mario ^a   Del Principe, Domenico ^a   Amadori, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Adult ALL; Bcl 2; Flow cytometry; P glycoprotein; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FLUDARABINE; GLYCOPROTEIN P; GLYCOPROTEIN P ANTIBODY; MITOXANTRONE; MONOCLONAL ANTIBODY; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 2 ANTIBODY; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0037832626     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04343.x     Document Type: Article

References (41)

1. Annino, L., Vegna, M.L., Camera, A., Specchia, G., Visani, G., Fioritoni, G., Ferrara, F., Peta, A., Ciolli, S., Deplano, W., Fabbiano, F., Sica, S., Di Raimondo, F., Cascavilla, N., Tabilio, A., Leoni, P., Invernizzi, R., Baccarani, M., Rotoli, B., Amadori, S. & Mandelli, F. (2002) Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA 0288 randomized study. Blood, 99, 863-871.
2. Bassan, R., Pogliani, E., Casula, P., Rossi, G., Fabris, P., Moranti, S., Lambertenghi-Deliliers, G., Vespignani, M., Lerede, T., Rambaldi, A., Borleri, G., Spedini, P., Cortelezzi, A., Izzi, T., Coser, P., Broccia, G., Corneo, G. & Barbui, T. (2001) Risk-oriented post-remission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopietic stem cell transplants in high-risk groups. Hematology Journal, 2, 117-126.
3. Beck, J., Niethammer, D. & Gekeler, V. (1996) MDR1, MRP, topoisomerase IIα/β, and cyclin A gene expression in acute and chronic leukemias. Leukemia, 10, s39-s45.
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. British Journal of Haematology, 33, 451-458.
5. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D. & Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute non-lymphoblastic leukemia cells at diagnosis. Blood, 79, 473-476.
6. Campos, L., Rouault, J.-P., Sabido, O., Oriol, P., Rouby, N., Vasselon, C., Archimbaud, E., Magaud, J.P. & Guyotat, D. (1993) High expression of bcl-2 protein in acute myeloid leukemia is associated with poor response to chemotherapy. Blood, 81, 3091-3096.
7. Charpin, C., Garcia, S., Bonnier, P., Martini, F., Andrac, L., Horschowski, N., Lavaut, M.N. & Allasia, C. (1998) Bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlations with 10-year follow-up. Journal of Clinical Oncology, 16, 2025-2031.
8. Coustan-Smith, E., Kitanaka, A., Pui, C.H., McNinch, L., Evans, W.E., Raimondi, S.C., Behm, F.G., Arico, M. & Campana, D. (1996) Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood, 87, 1140-1146.
9. Dalton, W.S., Grogan, T.M., Rybski, J.A., Scheper, R.J., Richter, L., Kailey, J., Broxterman, H.J., Pinedo, H.M. & Salmon, S.E. (1989) Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug resistant myeloma cells: association with level of drug resistance and drug accumulation. Blood, 73, 747-752.
10. Damiani, D., Michelutti, A., Michieli, M., Masolini, P., Stocchi, R., Geromin, A., Ermacora, A., Russo, D., Fanin, R. & Baccarani, M. (2002) P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. British Journal of Haematology. 116, 519-527.
11. Del Poeta, G., Stasi, R., Venditti, A., Suppo, G., Aronica, G., Bruno, A., Masi, M., Tabilio, A. & Papa, G. (1994) Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia. 8, 388-394.
12. Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S. & Papa, G. (1996) Clinical relevance of P-glycoprotein expression in de novo acute myeloid leucemia. Blood, 87, 1997-2004.
13. Del Poeta, G., Buccisano, F., Maurillo, L., Venditti, A., Cox, M.C., Tamburini, A., Morino, L., Riccitelli, A., Postorino, M., Del Principe, M.I., Cudillo, L., Del Moro, B., Masi, M. & Amadori, S. (1999) Dose-intensive therapy including stem-cell transplantation improves outcome in adult acute lymphoid leukemia (ALL). Haematologica, 84, 72.
14. Den Boer, M.L., Zwaan, C.M., Pieters, R., Kazemier, K.M., Rottier, M.M., Flens, M.J., Scheper, R.J. & Veerman, A.J. (1997) Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia. 11, 1078-1085.
15. Dhooge, C., De Moerloose, B., Laureys, G., Kint, J., Ferster, A., De Bacquer, D., Philippe, J. & Benoit, Y. (1999) P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study. British Journal of Haematology. 105, 676-683.
16. Durrant, I.J., Prentice, H.G. & Richards, S.M. (1997) Intensification of treatment for adults with acute lymphoblastic leukaemia: results of UK Medical Research council randomized trial UKALL XA. British Journal of Haematology, 99, 84-92.
17. Goasguen, J.E., Dossot, J.-M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., LePrise, P.Y., Chaperon, J. & Fauchet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81, 2394-2398.
18. Goasguen, J.E., Lamy, T., Bergeron, C., Ly Sunaram, B., Mordelet, E., Gorre, G., Dossot, J.M., Le Gall, E., Grosbois, B,. LePrise, P.Y. & Fauchet, R. (1996) Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome. Leukemia and Lymphoma, 23, 567-576.
19. Haldar, S., Jena, N. & Croce, C.M. (1995) Inactivation of Bcl-2 by phosphorylation. Proceedings of National Academy of Sciences of the United States of America, 92, 4507-4511.
20. Hermine, O., Haioun, C., Lepade, E., d'Agay, M.F., Triere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J.P., Diebold, J., Reyas, F. & Gaulard, P. (1996) Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Blood, 87, 265-272.
21. Hoelzer, D. & Gökbuget. N. (2000) New approaches in acute lymphoblastic leukemia in adults: where do we go? Seminars in Oncology, 27, 540-559.
22. Hoelzer, D., Thiel, E., Ludwig, W.D., Loffler, H., Buchner, T., Freund, M., Heil, G., Hiddemann, W., Maschmeyer, G. & Volkers, B. (1993) Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group. Leukemia. 7. s130-s134.
23. Kanerva, J., Tiirikainen, M.I., Makipernaa, A., Riikonen, P., Mottonen, M., Salmi, T.T., Krusius, T. & Saarinen-Pihkala, U.M. (2001) Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up. Pediatric Hematology and Oncology, 18, 27-36.
24. Kantarjian, H.M., O'Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, C.S., Keating, M.J., Murphy, S. & Freireich, E.J. (2000) Results of treatment with hyper-CVAD, a dose intensive regimen, in adult acute lymphocytic leukemia. Journal of Clinical Oncology, 18, 547-561.
25. Klimecki, W.T., Futscher, B.W., Grogan, T.M. & Dalton, W.S. (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83, 2451-2458.
26. Ludescher, C., Hile, W., Eisterer, W. & Thaler, J. (1993) Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay. Blood, 82, 3505-3506.
27. Marie, J.P., Zittoun, R. & Siki, B.I. (1991) Multidrug resistance (MDR1) gene expression in adult acute leukemia: correlation with treatment outcome and in vitro drug sensitivity. Blood, 78, 586-592.
28. Nussler, V., Pelka-Fleischer, R., Zwierzina, H., Nerl, C., Beckert, B., Gieseler, F., Diem, H., Ledderose, G., Gullis, E., Sauer, H. & Wilmanns, W. (1996) P-glycoprotein expression in patients with acute leukemia-clinical relevance. Leukemia, 3. s23-s31.
29. Reed, J.C., Miyashita, T., Takayama, S., Wang, H.G., Sato, T., Krajewski, S., Aime-Sempe, C., Bodrug, S., Kitada, S. & Hanada, M. (1996) Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. Journal of Cellular Biochemistry. 60, 23-32.
30. Robertson, L.E., Plunkett, W., McConnell, K., Keating, M.J. & McDonnell, T.J. (1996) Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome, Leukemia, 10, 456-459.
31. Rothenberg, M.L., Mickley, L.A., Cole, D.E., Balis, F.M., Tsuruo, T., Poplack, D.G. & Fojo, A.T. (1989) Expression of the MDR1/P170 gene in patients with acute lymphoblastic leukemia. Blood, 74, 1388-1395.
32. Savignano, C., Geromin, A., Michieli, M., Damiani, D., Michelutti, A., Melli, C., Fanin, R. & Baccarani, M. (1993) The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. Haematologica, 78, 261-263.
33. Scheper, R.J., Bulte, J.W.M., Brakker, J.G.P., Quack, J.J., Van Der Schoot, E., Balm, A.J., Meijer, C.J., Broxterman, H.J., Kuiper, C.M., Lankelma, J. & Pinedo, H.M. (1988) Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance. British Journal of Cancer, 42, 389-394.
34. Schimmer, A.D., Hedley, D.W., Penn, L.Z. & Minden, M.D. (2001) Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood. 98, 3541-3553.
35. Schinkel, A.H., Roelofs, E.M. & Borst, P. (1991) Characterization of human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Research, 51, 2628-2635.
36. Sobol, R.E., Royston, I., LeBien, T.W., Minowada, J., Anderson, K., Davey, F.R., Cuttner, J., Schiffer, C., Ellison, R.R. & Bloomfield, C.D. (1985) Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood, 65, 730-735.
37. Stasi, R., Del Poeta, G., Masi, M., Tribalto, M., Venditti, A., Papa, G., Nicoletti, B., Vernole, P., Tedeschi, B., Delaroche, I., Mingarelli, M. & Dallapiccola, B. (1993) Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. Cancer Genetics and Cytogenetics, 67, 28-34.
38. Tafuri, A., Gregorj, C., Petrucci, M.T., Ricciardi, M.G., Mancini, M., Cimino, G., Mecucci, C., Tedeschi, A., Fioritoni, G., Ferrara, F., Di Raimondo, F., Gallo, E., Liso, V., Fabbiano, F., Cascavilla, N., Pizzolo, G., Camera, A., Pane, F., Lanza, F., Cilloni, D., Annino, L., Vitale, A., Vegna, M.L., Vignetti, M., Foà, R. & Mandelli, F. for the GIMEMA Group (2002) MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood, 100, 974-981.
39. Thiebaut, A., Vernant, J.P., Degos, L., Huguet, F.R., Reiffers, J., Sebban, C., Lepage, E., Thomas, X. & Fiere, D. (2000) Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematology and Oncology Clinics of North America, 14, 1353-1366.
40. Wuchter, C., Leonid, K., Ruppert, V., Schrappe, M., Buchner, T., Schoch, C., Haferlach, T., Harbott, J., Ratei, R., Dorken, B. & Ludwig, W.D. (2000a) Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy. relapse rate and overall survival in acute leukemia. Haematologica, 85, 711-721.
41. Wuchter, C., Karawajew, L., Ruppert, V., Schrappe, M., Harbott, J., Ratei, R., Dorken, B. & Ludwig, W.D. (2000b) Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukemia. British Journal of Haematology, 110, 154-160.